I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
2-years outcomes of the treat-to-target strategy in early p..:
E. Yu. Loginova
;
T. V. Korotaeva
;
E. E. Gubar
...
https://rsp.mediar-press.net/rsp/article/view/3226/2230. , 2022
Link:
https://rsp.mediar-press.net/rsp/article/view/3226
RT Journal T1
2-years outcomes of the treat-to-target strategy in early psoriatic arthritis ; Результаты двухлетнего наблюдения в рамках стратегии «Лечение до достижения цели» когорты больных ранним псориатическим артритом
UL https://suche.suub.uni-bremen.de/peid=base-ftjrsp:oai:oai.rsp.elpub.ru:article_3226&Exemplar=1&LAN=DE A1 E. Yu. Loginova A1 T. V. Korotaeva A1 E. E. Gubar A1 P. O. Tremaskina A1 S. I. Glukhova A1 E. L. Nasonov A1 Е. Ю. Логинова A1 Т. В. Коротаева A1 Е. Е. Губарь A1 П. О. Тремаскина A1 С. И. Глухова A1 Е. Л. Насонов PB IMA-PRESS, LLC YR 2022 K1 генно-инженерные биологические препараты K1 "treat-to-target" strategy K1 remission K1 minimal disease activity K1 methotrexate K1 biological DMARD K1 стратегия «лечение до достижения цели» K1 ремиссия K1 минимальная активность заболевания K1 метотрексат JF https://rsp.mediar-press.net/rsp/article/view/3226/2230 LK http://dx.doi.org/https://rsp.mediar-press.net/rsp/article/view/3226 DO https://rsp.mediar-press.net/rsp/article/view/3226 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)